Yoshinari Takasaki 研究室

AI 要約（直近 5 年の研究成果）

※ AI（Claude）が、公開されている論文要旨から研究の問い・手法・主要な発見を事実情報として抽出・再構成して自動生成しています。誤りを含む可能性があるため、正確性は研究室公式情報でご確認ください。

研究成果（8 件）

• [2025] Three-year safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Final analysis of an all-case postmarketing surveillance study
  DOI: https://doi.org/10.1093/mr/roaf017
• [2025] Anti‐AHNAK1 Antibodies Are a Novel Diagnostic Biomarker for Systemic Lupus Erythematosus
  DOI: https://doi.org/10.1155/bmri/6381475
• [2023] Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance
  DOI: https://doi.org/10.1093/mr/road063
• [2023] Current Therapy of Rheumatoid Arthritis
  DOI: https://doi.org/10.2531/spinalsurg.37.214
• [2022] Chemoprophylaxis against <i>Pneumocystis jirovecii</i> pneumonia in Japanese patients with ANCA-associated vasculitis: An observational study
  DOI: https://doi.org/10.1093/mr/roac124
• [2022] Abatacept ameliorates both glandular and extraglandular involvements in patients with Sjögren’s syndrome associated with rheumatoid arthritis: Findings from an open-label, multicentre, 1-year, prospective study: The ROSE (Rheumatoid Arthritis with Orencia Trial Toward Sjögren’s Syndrome Endocrinopathy) and ROSE II trials
  DOI: https://doi.org/10.1093/mr/roac011
• [2022] A three-generation Muckle–Wells syndrome family: Detailed family history, physical examination, and inter-departmental collaboration
  DOI: https://doi.org/10.1093/mrcr/rxab037
• [2021] Exploratory classification of clinical phenotypes in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis using cluster analysis
  DOI: https://doi.org/10.1038/s41598-021-84627-6

科研費（0 件）

まだデータがありません（KAKEN 取り込み後に表示）。

所属学会・役職（0 件）

まだデータがありません（学会データ連携後に表示）。